These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Valdez GR; Roberts AJ; Chan K; Davis H; Brennan M; Zorrilla EP; Koob GF Alcohol Clin Exp Res; 2002 Oct; 26(10):1494-501. PubMed ID: 12394282 [TBL] [Abstract][Full Text] [Related]
26. Effects of the glucocorticoid antagonist, mifepristone, on the consequences of withdrawal from long term alcohol consumption. Jacquot C; Croft AP; Prendergast MA; Mulholland P; Shaw SG; Little HJ Alcohol Clin Exp Res; 2008 Dec; 32(12):2107-16. PubMed ID: 18828802 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study. Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071 [TBL] [Abstract][Full Text] [Related]
28. Ethanol drinking and deprivation alter dopaminergic and serotonergic function in the nucleus accumbens of alcohol-preferring rats. Thielen RJ; Engleman EA; Rodd ZA; Murphy JM; Lumeng L; Li TK; McBride WJ J Pharmacol Exp Ther; 2004 Apr; 309(1):216-25. PubMed ID: 14718606 [TBL] [Abstract][Full Text] [Related]
29. Ability of baclofen in reducing alcohol craving and intake: II--Preliminary clinical evidence. Addolorato G; Caputo F; Capristo E; Colombo G; Gessa GL; Gasbarrini G Alcohol Clin Exp Res; 2000 Jan; 24(1):67-71. PubMed ID: 10656195 [TBL] [Abstract][Full Text] [Related]
30. Effects of ritanserin on ethanol withdrawal-induced anxiety in rats. Gatch MB; Wallis CJ; Lal H Alcohol; 2000 May; 21(1):11-7. PubMed ID: 10946153 [TBL] [Abstract][Full Text] [Related]
31. The effects of ritanserin on mood, sleep, vigilance, clinical impression, and social functioning in alcohol-dependent individuals. Ritanserin in Alcoholism Work Group. Wiesbeck GA; Weijers HG; Chick J; Boening J Alcohol Alcohol; 2000; 35(4):384-9. PubMed ID: 10906006 [TBL] [Abstract][Full Text] [Related]
32. Lack of stimulant and anxiolytic-like effects of ethanol and accelerated development of ethanol dependence in mu-opioid receptor knockout mice. Ghozland S; Chu K; Kieffer BL; Roberts AJ Neuropharmacology; 2005 Sep; 49(4):493-501. PubMed ID: 15961126 [TBL] [Abstract][Full Text] [Related]
33. Behavioral consequences of repeated nicotine during adolescence in alcohol-preferring AA and alcohol-avoiding ANA rats. Kemppainen H; Hyytiä P; Kiianmaa K Alcohol Clin Exp Res; 2009 Feb; 33(2):340-9. PubMed ID: 19032573 [TBL] [Abstract][Full Text] [Related]
34. Effect of acetyl-L-carnitine on ethanol consumption and alcohol abstinence syndrome in rats. Mangano NG; Clementi G; Costantino G; Calvani M; Matera M Drugs Exp Clin Res; 2000; 26(1):7-12. PubMed ID: 10761531 [TBL] [Abstract][Full Text] [Related]
35. The decreased phosphorylation of cyclic adenosine monophosphate (cAMP) response element binding (CREB) protein in the central amygdala acts as a molecular substrate for anxiety related to ethanol withdrawal in rats. Pandey SC; Roy A; Zhang H Alcohol Clin Exp Res; 2003 Mar; 27(3):396-409. PubMed ID: 12658105 [TBL] [Abstract][Full Text] [Related]
36. WHO/ISBRA Study on State and Trait Markers of Alcohol Use and Dependence: analysis of demographic, behavioral, physiologic, and drinking variables that contribute to dependence and seeking treatment. International Society on Biomedical Research on Alcoholism. Glanz J; Grant B; Monteiro M; Tabakoff B; Alcohol Clin Exp Res; 2002 Jul; 26(7):1047-61. PubMed ID: 12170115 [TBL] [Abstract][Full Text] [Related]
37. Ritanserin in relapse prevention in abstinent alcoholics: results from a placebo-controlled double-blind international multicenter trial. Ritanserin in Alcoholism Work Group. Wiesbeck GA; Weijers HG; Chick J; Naranjo CA; Boening J Alcohol Clin Exp Res; 1999 Feb; 23(2):230-5. PubMed ID: 10069551 [TBL] [Abstract][Full Text] [Related]
38. The relevance of pharmacological studies to sleep research in psychiatry. Janssen PA Pharmacopsychiatry; 1988 Jan; 21(1):33-7. PubMed ID: 3129746 [TBL] [Abstract][Full Text] [Related]
39. Administration of low doses of MK-801 during ethanol withdrawal in the developing rat pup attenuates alcohol's teratogenic effects. Thomas JD; Fleming SL; Riley EP Alcohol Clin Exp Res; 2002 Aug; 26(8):1307-13. PubMed ID: 12198409 [TBL] [Abstract][Full Text] [Related]
40. Advances in the use of naltrexone: an integration of preclinical and clinical findings. O'Malley SS; Froehlich JC Recent Dev Alcohol; 2003; 16():217-45. PubMed ID: 12638640 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]